NICE hits out at 'flawed and inaccurate' cancer care report

An international report that claims the UK has among the worst access to cancer drugs is 'flawed' and 'inaccurate', the National Institute for Health and Clinical Excellence has said.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here